Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grant

Showing results (21-30 of 386) with videos related to

Pageof 39
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Targeting histone demethylases in cancer therapySteven Grant
Blood|May 10, 2014
Bortezomib resistance and MUC1 in myelomaSteven Grant
Haematologica|November 17, 2022
Disrupting autophagy in <i>FLT3</i>-mutant acute myeloid leukemiaSteven Grant
Methods in Molecular Biology (Clifton, N.J.)|August 27, 2011
Methods to study cancer therapeutic drugs that target cell cycle checkpointsYun Dai, Steven Grant
Expert Review of Hematology|September 24, 2011
Combining proteasome with cell cycle inhibitors: a dual attack potentially applicable to multiple hematopoietic malignanciesBeata Holkova, Steven Grant
Reviews in Clinical and Experimental Hematology|February 7, 2004
Apoptosis regulatorsHisashi Harada, Steven Grant
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Kinase inhibitors and cytotoxic drug resistanceSteven Grant, Paul Dent
Leukemia Research|July 6, 2014
Orphan drug designation for pracinostat, volasertib and alvocidib in AMLPrithviraj Bose, Steven Grant
Blood Reviews|March 15, 2016
Update on rational targeted therapy in AMLDanielle Shafer, Steven Grant
Expert Opinion on Investigational Drugs|July 1, 2020
Enhancing venetoclax activity in hematological malignanciesToshihisa Satta, Steven Grant
Pageof 39

Showing results (21-30 of 386) with videos related to

Sort By:
Pageof 39
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Targeting histone demethylases in cancer therapySteven Grant
Blood|May 10, 2014
Bortezomib resistance and MUC1 in myelomaSteven Grant
Haematologica|November 17, 2022
Disrupting autophagy in <i>FLT3</i>-mutant acute myeloid leukemiaSteven Grant
Methods in Molecular Biology (Clifton, N.J.)|August 27, 2011
Methods to study cancer therapeutic drugs that target cell cycle checkpointsYun Dai, Steven Grant
Expert Review of Hematology|September 24, 2011
Combining proteasome with cell cycle inhibitors: a dual attack potentially applicable to multiple hematopoietic malignanciesBeata Holkova, Steven Grant
Reviews in Clinical and Experimental Hematology|February 7, 2004
Apoptosis regulatorsHisashi Harada, Steven Grant
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Kinase inhibitors and cytotoxic drug resistanceSteven Grant, Paul Dent
Leukemia Research|July 6, 2014
Orphan drug designation for pracinostat, volasertib and alvocidib in AMLPrithviraj Bose, Steven Grant
Blood Reviews|March 15, 2016
Update on rational targeted therapy in AMLDanielle Shafer, Steven Grant
Expert Opinion on Investigational Drugs|July 1, 2020
Enhancing venetoclax activity in hematological malignanciesToshihisa Satta, Steven Grant
Pageof 39